Upgrades/Downgrades
Updated: 09-Oct-26 12:05 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Webull Corporation | BULL | Scotiabank | Sector Perform » Sector Outperform | $9 | |
| V.F. Corp | VFC | JP Morgan | Underweight » Neutral | $18 | |
| Jack Henry | JKHY | Piper Sandler | Neutral » Overweight | $175 | |
| Humana | HUM | Robert W. Baird | Neutral » Outperform | $596 | |
| Fastly | FSLY | Oppenheimer | Perform » Outperform | $35 | |
| Cboe Global Markets | CBOE | Morgan Stanley | Underweight » Overweight | $358 | |
| ArcelorMittal | MT | UBS | Neutral » Buy | ||
| Houlihan Lokey | HLI | Citizens | Mkt Perform » Mkt Outperform | $175 | |
| ICON plc | ICLR | BofA Securities | Underperform » Neutral | $185 | |
| Elastic | ESTC | Monness Crespi & Hardt | Neutral » Buy | $120 | |
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Voya Financial | VOYA | Keefe Bruyette | Outperform » Mkt Perform | $108 | |
| South Bow Corporation | SOBO | Barclays | Equal Weight » Underweight | $33 | |
| Smithfield Foods | SFD | BofA Securities | Buy » Neutral | $21 | |
| Semtech | SMTC | Northland Capital | Outperform » Market Perform | ||
| Ryanair Hldgs | RYAAY | Barclays | Overweight » Equal Weight | ||
| Knife River Corp. | KNF | RBC Capital Mkts | Outperform » Sector Perform | $58 | |
| Genworth Financial | GNW | Keefe Bruyette | Outperform » Mkt Perform | $10.50 | |
| Gemini Space Station | GEMI | Morgan Stanley | Equal-Weight » Underweight | $4.75 | |
| Astera Labs | ALAB | Northland Capital | Outperform » Market Perform | ||
| Alignment Healthcare | ALHC | William Blair | Outperform » Mkt Perform | ||
| Pearson Plc | PSO | UBS | Buy » Neutral | ||
| Pershing Square, Inc. | PS | Citigroup | Neutral » Sell | $45 | |
| DuPont | DD | JP Morgan | Overweight » Neutral | $145 | |
| Illinois Tool Works | ITW | JP Morgan | Overweight » Neutral | $270 | |
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| York Space Systems | YSS | Barclays | Equal Weight | $11 | |
| Synchrony Financial | SYF | BMO Capital Markets | Market Perform | $81 | |
| SpaceX | SPCX | Barclays | Overweight | $254 | |
| RTX | RTX | Barclays | Overweight | $223 | |
| Rocket Lab USA | RKLB | Barclays | Overweight | $85 | |
| Quince Therapeutics | QNCX | Raymond James | Outperform | $72 | |
| Planet Labs | PL | Barclays | Equal Weight | $17 | |
| Penguin Solutions | PENG | BofA Securities | Buy | $100 | |
| Palisade Bio | PALI | Raymond James | Outperform | $6 | |
| Palantir Technologies | PLTR | Barclays | Overweight | $265 | |
| Ovid Therapeutics | OVID | Cantor Fitzgerald | Overweight | ||
| Odyssey Therapeutics | ODTX | Raymond James | Outperform | $42 | |
| Northrop Grumman | NOC | Barclays | Underweight | $419 | |
| Nektar Therapeutics | NKTR | Raymond James | Mkt Perform | ||
| Mobility Global | MBGL | Morgan Stanley | Equal-Weight | $19 | |
| Mid Penn Bancorp | MPB | Piper Sandler | Overweight | $42 | |
| Lockheed Martin | LMT | Barclays | Equal Weight | $554 | |
| LB Pharmaceuticals | LBRX | Canaccord Genuity | Buy | $65 | |
| Kymera Therapeutics | KYMR | Raymond James | Outperform | $140 | |
| Kratos Defense and Security | KTOS | Barclays | Overweight | $90 | |
| Karman Space and Defense | KRMN | Barclays | Overweight | $79 | |
| IBM | IBM | Truist | Hold | $240 | |
| Firefly Aerospace | FLY | Barclays | Equal Weight | $34 | |
| El Pollo Loco | LOCO | Roth Capital | Buy | $22 | |
| Ducommun | DCO | Guggenheim | Buy | $246 | |
| Definium Therapeutics | DFTX | JP Morgan | Overweight | $84 | |
| Capital One | COF | BMO Capital Markets | Market Perform | $219 | |
| CAE | CAE | Barclays | Overweight | $38 | |
| C4 Therapeutics | CCCC | JP Morgan | Overweight | $10 | |
| Boeing | BA | Barclays | Overweight | $300 | |
| BETA Technologies | BETA | Barclays | Overweight | $35 | |
| American Express | AXP | BMO Capital Markets | Outperform | $380 | |
| AeroVironment | AVAV | Barclays | Equal Weight | $237 | |
| Southwest Gas | SWX | Wolfe Research | Peer Perform | $92 | |
| Sanofi | SNY | Wolfe Research | Peer Perform | ||
| GSK plc | GSK | Wolfe Research | Outperform | $70 | |
| Fortune Brands Innovations | FBIN | Citigroup | Buy | $48 | |
| RMR Group | RMR | Maxim Group | Buy | $26 | |
| Plains All American | PAA | Jefferies | Buy | $27 | |
| Duos Technologies Group | DUOT | Chardan Capital Markets | Neutral | $9.50 | |
| BellRing Brands | BRBR | BNP Paribas Exane | Outperform | $12 | |
| Simon Properties | SPG | BNP Paribas Exane | Neutral | $222 | |
| Macerich | MAC | BNP Paribas Exane | Outperform | $28 | |
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Vertical Aerospace Group | EVTL | Barclays | Equal Weight | $1 | |
| Joby Aviation | JOBY | Barclays | Underweight | $4 | |
| Archer Aviation | ACHR | Barclays | Overweight | $8 | |
| Trane | TT | JP Morgan | Overweight | $550 | |
| Carrier Global | CARR | JP Morgan | Neutral | $61 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |